Swiss National Bank Ligand Pharmaceuticals Inc Transaction History

Swiss National Bank

$150 Billion
Q3 2024

A detailed history of Swiss National Bank transactions in Ligand Pharmaceuticals Inc stock. As of the latest transaction made, Swiss National Bank holds 35,100 shares of LGND stock, worth $4.21 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

35,100

Previous 33,100 6.04%

Holding current value

$4.21 Million

Previous $2.79 Million 26.03%

% of portfolio

0.0%

Previous 0.0%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 07, 2024	BUY	$82.7 - $110.11 $165,400 - $220,220	2,000 Added 6.04%	35,100 $3.52 Million
Q2 2024 Aug 08, 2024	BUY	$68.53 - $87.91 $27,412 - $35,164	400 Added 1.22%	33,100 $2.79 Million
Q1 2024 May 07, 2024	BUY	$68.64 - $89.2 $13,728 - $17,840	200 Added 0.62%	32,700 $2.39 Million
Q4 2023 Feb 06, 2024	SELL	$49.57 - $72.63 $178,452 - $261,467	-3,600 Reduced 9.97%	32,500 $2.32 Million
Q3 2023 Nov 08, 2023	BUY	$58.86 - $72.67 $47,088 - $58,136	800 Added 2.27%	36,100 $2.16 Million
Q2 2023 Aug 09, 2023	SELL	$69.53 - $79.33 $83,436 - $95,196	-1,200 Reduced 3.29%	35,300 $2.55 Million
Q1 2023 May 10, 2023	SELL	$65.67 - $77.08 $275,814 - $323,736	-4,200 Reduced 10.32%	36,500 $2.68 Million
Q4 2022 Feb 08, 2023	BUY	$61.72 - $96.74 $43,204 - $67,718	700 Added 1.75%	40,700 $2.72 Million
Q3 2022 Nov 09, 2022	BUY	$0.01 - $107.56 $5 - $53,780	500 Added 1.27%	40,000 $3.44 Million
Q1 2022 May 09, 2022	BUY	$94.99 - $151.56 $265,972 - $424,368	2,800 Added 7.63%	39,500 $4.44 Million
Q4 2021 Feb 08, 2022	SELL	$127.69 - $165.85 $12,769 - $16,585	-100 Reduced 0.27%	36,700 $5.67 Million
Q3 2021 Nov 08, 2021	BUY	$102.33 - $144.73 $20,466 - $28,945	200 Added 0.55%	36,800 $5.13 Million
Q2 2021 Aug 06, 2021	SELL	$113.03 - $155.64 $22,606 - $31,127	-200 Reduced 0.54%	36,600 $4.8 Million
Q1 2021 May 07, 2021	BUY	$99.52 - $215.83 $39,808 - $86,332	400 Added 1.1%	36,800 $5.61 Million
Q3 2020 Nov 09, 2020	SELL	$89.56 - $126.72 $35,824 - $50,688	-400 Reduced 1.09%	36,400 $3.47 Million
Q2 2020 Aug 05, 2020	BUY	$68.28 - $123.65 $184,356 - $333,855	2,700 Added 7.92%	36,800 $4.12 Million
Q1 2020 May 08, 2020	SELL	$63.37 - $107.88 $145,751 - $248,124	-2,300 Reduced 6.32%	34,100 $2.48 Million
Q4 2019 Feb 06, 2020	SELL	$96.94 - $113.59 $29,082 - $34,077	-300 Reduced 0.82%	36,400 $3.8 Million
Q3 2019 Nov 12, 2019	SELL	$86.25 - $120.16 $112,125 - $156,208	-1,300 Reduced 3.42%	36,700 $3.65 Million
Q2 2019 Aug 02, 2019	SELL	$107.38 - $129.34 $85,904 - $103,472	-800 Reduced 2.06%	38,000 $4.34 Million
Q1 2019 May 10, 2019	BUY	$105.93 - $142.47 $169,488 - $227,952	1,600 Added 4.3%	38,800 $4.88 Million
Q3 2018 Nov 08, 2018	BUY	$211.18 - $274.49 $105,590 - $137,245	500 Added 1.36%	37,200 $10.2 Million
Q1 2018 May 04, 2018	BUY	$138.63 - $182.62 $41,589 - $54,786	300 Added 0.82%	36,700 $6.06 Million
Q4 2017 Feb 07, 2018	BUY	$128.36 - $147.04 $192,540 - $220,560	1,500 Added 4.3%	36,400 $4.98 Million
Q3 2017 Nov 03, 2017	BUY	$120.91 - $137.94 $4.22 Million - $4.81 Million	34,900	34,900 $4.75 Million

Others Institutions Holding LGND

# of Institutions

257

Shares Held

18.2M

Call Options Held

26.8K

Put Options Held

9.3K

View Full List

About LIGAND PHARMACEUTICALS INC

Ticker LGND
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 16,882,800
Market Cap $2.02B
Description
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Veklury for the treatment of moderate or severe COVID-19;...

More about LGND

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Swiss National Bank, based on Form 13F filings with the SEC.

News

Stay updated on Swiss National Bank with notifications on news.

Account

Swiss National Bank Ligand Pharmaceuticals Inc Transaction History